Literature DB >> 3647677

Platelet aggregation induced by ether-linked phospholipids. 1. Inhibitory actions of bovine serum albumin and structural analogues of platelet activating factor.

A Tokumura, J Yoshida, T Maruyama, K Fukuzawa, H Tsukatani.   

Abstract

Ether-linked lysophosphatidic acid was able to induce aggregation of platelets from various animals. Feline platelets were the most sensitive followed in decreasing order by human, bovine and rabbit platelets. ONO-6240 and CV-3988, which are antagonists of platelet activating factor, did not inhibit aggregation of feline platelets induced by ether-linked lysophosphatidic acid, indicating that the aggregation induced by the lysophosphatidic acid did not involve receptors for platelet activating factor. An addition of bovine serum albumin caused dose-dependent inhibitions on the aggregation of platelets by both ether-linked lysophosphatidic acid and platelet activating factor. Moreover, 0.5% bovine serum albumin reversed platelet aggregation by the active phospholipid before this aggregation reached a maximum. These results suggest that the lysophosphatidic acid exerts its stimulatory action extracellularly, probably by interacting with specific sites on the surface of platelet.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3647677     DOI: 10.1016/0049-3848(87)90206-4

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  9 in total

1.  Influence of plasma protein content and platelet number on the potency of PAF and its antagonist RP 59227 in rabbit platelet preparations.

Authors:  A Floch; I Cavero
Journal:  Br J Pharmacol       Date:  1990-05       Impact factor: 8.739

2.  Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.

Authors:  Akira Tokumura; Junya Sinomiya; Seishi Kishimoto; Tamotsu Tanaka; Kentaro Kogure; Takayuki Sugiura; Kiyoshi Satouchi; Keizo Waku; Kenji Fukuzawa
Journal:  Biochem J       Date:  2002-08-01       Impact factor: 3.857

3.  Platelet-activating factor (PAF) inhibitory profile of KO-286011 on blood platelets in vitro and in vivo.

Authors:  G Ostermann; B Hofmann; H P Kertscher; U Till
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-12       Impact factor: 3.000

4.  Hen egg yolk and white contain high amounts of lysophosphatidic acids, growth factor-like lipids: distinct molecular species compositions.

Authors:  S Nakane; A Tokumura; K Waku; T Sugiura
Journal:  Lipids       Date:  2001-04       Impact factor: 1.880

5.  Albumin inhibits platelet-activating factor (PAF)-induced responses in platelets and macrophages: implications for the biologically active form of PAF.

Authors:  G Grigoriadis; A G Stewart
Journal:  Br J Pharmacol       Date:  1992-09       Impact factor: 8.739

6.  Albumin therapy improves local vascular dynamics in a rat model of primary microvascular thrombosis: a two-photon laser-scanning microscopy study.

Authors:  Anitha Nimmagadda; Hee-Pyoung Park; Ricardo Prado; Myron D Ginsberg
Journal:  Stroke       Date:  2007-11-21       Impact factor: 7.914

7.  Vitamin E. deficiency increases the synthesis of platelet-activating factor (PAF) in rat polymorphonuclear leucocytes.

Authors:  K Fukuzawa; Y Kurotori; A Tokumura; H Tsukatani
Journal:  Lipids       Date:  1989-03       Impact factor: 1.880

8.  Albumin therapy augments the effect of thrombolysis on local vascular dynamics in a rat model of arteriolar thrombosis: a two-photon laser-scanning microscopy study.

Authors:  Hee-Pyoung Park; Anitha Nimmagadda; Richard A DeFazio; Raul Busto; Ricardo Prado; Myron D Ginsberg
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

Review 9.  Plasmalogens, platelet-activating factor and beyond - Ether lipids in signaling and neurodegeneration.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Isabella Wimmer; Johannes Berger
Journal:  Neurobiol Dis       Date:  2020-08-28       Impact factor: 5.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.